Nautilus Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Nautilus Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$711K	Buy	12,345 +4,688	+61%	+$269K	0.42%	69
2026 Q1	$464K	Sell	7,657 -76	-1%	-$4.43K	0.32%	88
2025 Q4	$417K	Sell	7,733 -1,292	-14%	-$62.2K	0.27%	102
2025 Q3	$407K	Sell	9,025 -472	-5%	-$22K	0.27%	105
2025 Q2	$440K	Sell	9,497 -149	-2%	-$7.31K	0.32%	85
2025 Q1	$588K	Sell	9,646 -100	-1%	-$5.83K	0.49%	63
2024 Q4	$551K	Buy	+9,746	New	+$545K	0.44%	67

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Nautilus Advisors's BMY Position: Q2 2026 in Review

Nautilus Advisors increased its Bristol-Myers Squibb (BMY) stake by 61% in Q2 2026, buying an estimated $269K and bringing the position to 12,345 shares worth $711K. The position accounts for 0.42% of the portfolio, ranked #69.

Nautilus Advisors first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. 1,086 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Nautilus Advisors held 12,345 shares of Bristol-Myers Squibb worth $711K as of Q2 2026.
Nautilus Advisors bought 4,688 Bristol-Myers Squibb shares in Q2 2026, an estimated $269K.
Bristol-Myers Squibb made up 0.42% of Nautilus Advisors's portfolio in Q2 2026, its #69 holding.
Nautilus Advisors first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
1,086 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Nautilus Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.